Fintel reports that on October 28, 2026, HC Wainwright & Co. initiated coverage of Lakewood-Amedex Biotherapeutics (NASDAQCM:LABT) with a Buy recommendation. This initiation represents the primary analyst activity for the company on this date.Prior to the rating action, the s